Hannuksela M L, Liinamaa M J, Kesäniemi Y A, Savolainen M J
Department of Internal Medicine, University of Oulu, Finland.
Atherosclerosis. 1994 Sep 30;110(1):35-44. doi: 10.1016/0021-9150(94)90065-5.
We investigated the interaction between genetic and environmental factors in the regulation of plasma HDL cholesterol concentration by determining TaqI and EcoN I restriction fragment length polymorphisms at the cholesteryl ester transfer protein (CETP) gene locus in 93 male alcohol drinkers and 82 control men. The highest plasma CETP activity and the lowest HDL cholesterol concentration were in the control subjects who were homozygous for the presence of the TaqI B restriction site (genotype 1-1). The lowest CETP activity and the highest HDL cholesterol among the control subjects were in those with genotype 2-2. These associations were, however, evident only in the non-smokers (P = 0.03 for CETP activity and P = 0.05 for HDL cholesterol). The non-smoking control subjects with genotype 1-1 had 19% higher CETP activity and 16% lower HDL cholesterol than those with genotype 2-2 (mean +/- S.D., 113 +/- 25 nmol/h/ml and 1.16 +/- 0.30 mmol/l vs. 95 +/- 16 nmol/h/ml and 1.38 +/- 0.34 mmol/l, respectively), and CETP activity and HDL cholesterol were negatively correlated (r = -0.280, P = 0.03, n = 59). The alcohol drinkers had 30% lower CETP activity (P < 0.001) and 48% higher HDL cholesterol (P < 0.001) than the controls. CETP activity was not affected by the TaqI B genotype in the alcohol drinkers. The lowest HDL cholesterol was in subjects with genotype 1-1 (1.68 +/- 0.60 mmol/l), but those with genotype 2-2 had lower HDL cholesterol than those with genotype 1-2 (1.78 +/- 0.59 and 1.93 +/- 0.66 mmol/l, respectively). The data of the alcohol drinkers fitted better with the quadratic regression model than with the linear one, suggesting a trend towards a curved relationship between the TaqI B genotype and HDL cholesterol in both the non-smoking and smoking alcohol drinkers. Total, LDL or VLDL cholesterol, total or VLDL triglycerides did not differ between the TaqI B genotypes either in the alcohol drinkers or the controls. Lipid and lipoprotein levels and CETP activities were likewise similar in the TaqI A and EcoN I polymorphisms. Our data indicate that CETP TaqI B polymorphism is related to plasma CETP activity and HDL cholesterol concentration in non-smoking men, but these associations are affected by smoking and alcohol drinking.
我们通过测定93名男性饮酒者和82名对照男性胆固醇酯转运蛋白(CETP)基因位点的TaqI和EcoN I限制性片段长度多态性,研究了遗传和环境因素在调节血浆高密度脂蛋白胆固醇浓度中的相互作用。血浆CETP活性最高且高密度脂蛋白胆固醇浓度最低的是TaqI B限制性位点纯合存在的对照受试者(基因型1-1)。对照受试者中CETP活性最低且高密度脂蛋白胆固醇最高的是基因型2-2的受试者。然而,这些关联仅在非吸烟者中明显(CETP活性P = 0.03,高密度脂蛋白胆固醇P = 0.05)。基因型1-1的非吸烟对照受试者的CETP活性比基因型2-2的受试者高19%,高密度脂蛋白胆固醇低16%(平均值±标准差,分别为113±25 nmol/h/ml和1.16±0.30 mmol/l vs. 95±16 nmol/h/ml和1.38±0.34 mmol/l),且CETP活性与高密度脂蛋白胆固醇呈负相关(r = -0.280,P = 0.03,n = 59)。饮酒者的CETP活性比对照组低30%(P < 0.001),高密度脂蛋白胆固醇高48%(P < 0.001)。饮酒者中CETP活性不受TaqI B基因型影响。基因型1-1的受试者高密度脂蛋白胆固醇最低(1.68±0.60 mmol/l),但基因型2-2的受试者的高密度脂蛋白胆固醇低于基因型1-2的受试者(分别为1.78±0.59和1.93±0.66 mmol/l)。饮酒者的数据与二次回归模型的拟合度优于线性模型,表明在非吸烟和吸烟饮酒者中,TaqI B基因型与高密度脂蛋白胆固醇之间存在曲线关系趋势。饮酒者和对照组中,TaqI B基因型之间的总胆固醇、低密度脂蛋白或极低密度脂蛋白胆固醇、总甘油三酯或极低密度脂蛋白甘油三酯均无差异。TaqI A和EcoN I多态性中的脂质和脂蛋白水平以及CETP活性同样相似。我们的数据表明,CETP TaqI B多态性与非吸烟男性的血浆CETP活性和高密度脂蛋白胆固醇浓度有关,但这些关联受吸烟和饮酒影响。